Latest news

June 23, 2020

BXTAccelyon wins 2020 MedTech Breakthrough Award

BXTAccelyon, the leading low dose rate brachytherapy partner to hospitals and clinics worldwide, and distribution partner for the PrecisionPoint™ freehand prostate biopsy system, is pleased to announce that MedTech Breakthrough has selected the PrecisionPoint Transperineal Access System™ as the ‘Best New Technology Solution - Biopsy’ in their 2020 Awards Program.

The ‘Best New Tec...

June 9, 2020

In the United Kingdom, Prostate Cancer is the most common cancer in men, with more than 47,500 diagnoses every year. With celebrities including Stephen Fry and Bill Turnbull announcing their own prostate cancer journey in recent years, the ‘Turnbull/Fry’ effect led to more men getting themselves checked for early warning signs and potentially saving themselves from adverse outcomes by getting an earlier diagnosis.

Their stories...

June 9, 2020

David Robb was a 68-year-old retired secondary school teacher from Peebles, Scotland when he was diagnosed with prostate cancer last Summer.

After two years of health checks following minor symptoms of LUTS, his PSA (prostate-specific antigen) level had risen from 3.8 from his first check in January 2017, to a score of 4.2 in July 2019.

David refused to undertake a rectal exam and a blind biopsy, which are the basic processes in...

May 19, 2020

THE SOUTH WEST CANCER ALLIANCE MOVES TOWARDS ERADICATION OF ‘TRUS’ PROSTATE CANCER BIOPSY

Bristol Urological Institute has hosted the first regional training course to teach the latest method of transperineal prostate cancer diagnosis

As part of a national campaign (TRExit) to completely remove transrectal prostate biopsies from the prostate cancer pathway, the first regional training course on freehand transperineal biopsies (L...

May 19, 2020

With the NHS declaring itself “open for business”, now is the time for any man who fears they might be displaying symptoms of potential prostate cancer to step forward. Increasing numbers of ‘COVID-free’ hospitals are being opened up, to provide essential care for those patients who may not have sought help, or whose care may have been delayed, during the lockdown phase.

Prostate cancer is the most diagnosed male cancer in the...

May 19, 2020

Beatriz Mora, Surgical Care Practitioner at North Bristol NHS Trust, describes how specialist urology practitioners are helping to transform prostate cancer care – and why the roles are perfect for any aspirational nurse who wants to improve the patient experience.

At the dawn of a new decade, UK prostate cancer care is at a critical juncture. 2020 began with confirmation that prostate cancer had overtaken breast cancer as the...

February 11, 2020

BXTAccelyon and Hitachi Medical Systems to support #TRexit

As the national campaign to eradicate traditional transrectal (TRUS) biopsies from the prostate cancer pathway gains momentum, BXTAccelyon is pleased to announce a training and promotion partnership with Hitachi Medical Systems UK.

Approaching 100 centres across England are now using the PrecisionPoint biopsy device, which allows transperineal (TP) biopsies to be conduct...

February 20, 2019

Dear Secretary of State,

Last year Mrs May pledged £75 million funding for prostate cancer research, paving the way for breakthroughs in the diagnosis, treatment and prevention of this most prevalent cancer in men in the UK. The recent NICE Guidance on prostate cancer has made a positive recommendation that all patients referred with suspected prostate cancer should have an MRI scan before a decision is made on prostate biopsy....

January 15, 2019

Chris Stone was a 66-year-old physically active, semi-retired senior banking executive when he was diagnosed with prostate cancer in early February 2017.

It was picked up during an annual private health check that indicated his PSA (prostate specific antigen) level had jumped from 3.5 to 5.4 in one year.

“I didn’t have any symptoms and felt fine. In fact, I go to the gym three times a week and play golf to a reasonable standard...

December 19, 2018

Back on the 30th November, in collaboration with Rick Popert and his team, we hosted our first ‘Urologists against TRUS biopsy’, or #TREXIT meeting at Guy's and St Thomas' NHS Foundation Trust. Hosted by Rick Popert and with over 35 of the NHS’ leading urologists and prostate cancer authorities including Prostate Cancer UK and the Accountable Cancer Network in attendance, the objective for the day was to discuss how TRUS biops...

Please reload

Recent Posts